FDA Inspection 1259740 — GlaxoSmithKline Biologicals Kft.
The FDA completed an inspection of GlaxoSmithKline Biologicals Kft. on Jan 31, 2025 in Godollo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 31, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Godollo (Hungary)